(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer

Monoclonal antibodies (mAbs) against the epidermal growth factor receptor (EGFR) are used in the treatment of advanced colorectal cancer (mCRC). Approximately 50% of patients benefit despite patient selection for RAS wild type (wt) tumors. Based on the hypothesis that tumor targeting is required for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Menke-van der Houven van Oordt, Catharina Willemien, Gootjes, Elske C., Huisman, Marc C., Vugts, Danielle J., Roth, Chantal, Luik, Anne Marije, Mulder, Emma R., Schuit, Robert C., Boellaard, Ronald, Hoekstra, Otto S., van Dongen, Guus AMS, Verheul, Henk M.W.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745807/
https://ncbi.nlm.nih.gov/pubmed/26309164
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky